As the SARS-CoV-2 pandemic continues to affect millions across the globe, the risk of coinfection with tuberculosis (TB) threatens patients' health and challenges our diagnostic capabilities. Here, we present a case of TB with pulmonary and laryngeal involvement complicated by coinfection with COVID-19. This case illustrates the importance of laboratory and imaging findings to differentiate between COVID-19 and TB and explores the potential for steroid use in laryngeal TB.